Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Primary cutaneous marginal zone B-cell lymphoma (PCMZL-MALT).

Literature DB >> 16870546

Primary cutaneous marginal zone B-cell lymphoma (PCMZL-MALT).

U Bohn-Sarmiento, D Aguiar-Bujanda, J Aguiar-Morales, M A Cabrera-Suárez.

Abstract

Entities: Disease

Mesh：

Year: 2006 PMID： 16870546 DOI： 10.1007/s12094-006-0057-1

Source DB: PubMed Journal: Clin Transl Oncol ISSN： 1699-048X Impact factor: 3.405

Keyword Cloud
References

× No keyword cloud information.

10 in total

1. Borrelia burgdorferi-associated cutaneous B cell lymphoma: clinical and immunohistologic characterization of four cases.

Authors: C Garbe; H Stein; D Dienemann; C E Orfanos
Journal: J Am Acad Dermatol Date: 1991-04 Impact factor: 11.527

Review 2. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.

Authors: R Willemze; H Kerl; W Sterry; E Berti; L Cerroni; S Chimenti; J L Diaz-Peréz; M L Geerts; M Goos; R Knobler; E Ralfkiaer; M Santucci; N Smith; J Wechsler; W A van Vloten; C J Meijer
Journal: Blood Date: 1997-07-01 Impact factor: 22.113

3. Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients.

Authors: Regina Fink-Puches; Paulus Zenahlik; Barbara Bäck; Josef Smolle; Helmut Kerl; Lorenzo Cerroni
Journal: Blood Date: 2002-02-01 Impact factor: 22.113

4. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma.

Authors: L Cerroni; N Zöchling; B Pütz; H Kerl
Journal: J Cutan Pathol Date: 1997-09 Impact factor: 1.587

5. Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy.

Authors: A H Sarris; I Braunschweig; L J Medeiros; M Duvic; C S Ha; M A Rodriguez; F B Hagemeister; P McLaughlin; J Romaguera; J Cox; F Cabanillas
Journal: J Clin Oncol Date: 2001-01-15 Impact factor: 44.544

10. Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: a clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy.

Authors: J U Rijlaarsdam; J Toonstra; O W Meijer; E M Noordijk; R Willemze
Journal: J Clin Oncol Date: 1996-02 Impact factor: 44.544

10 in total

Primary cutaneous marginal zone B-cell lymphoma (PCMZL-MALT).

1. Borrelia burgdorferi-associated cutaneous B cell lymphoma: clinical and immunohistologic characterization of four cases.

Review 2. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.

3. Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients.

4. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma.

5. Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy.

6. Primary cutaneous marginal zone B-cell lymphoma: clinical and therapeutic features in 50 cases.

7. Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study.

Review 8. Primary cutaneous B-cell lymphoma: review and current concepts.

Review 9. Classification of primary cutaneous lymphomas. Historical overview and perspectives.

10. Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: a clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy.